NZ513041A - N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists; their preparation and medicaments containing them - Google Patents

N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists; their preparation and medicaments containing them

Info

Publication number
NZ513041A
NZ513041A NZ513041A NZ51304101A NZ513041A NZ 513041 A NZ513041 A NZ 513041A NZ 513041 A NZ513041 A NZ 513041A NZ 51304101 A NZ51304101 A NZ 51304101A NZ 513041 A NZ513041 A NZ 513041A
Authority
NZ
New Zealand
Prior art keywords
triazolylmethyl
preparation
receptor antagonists
piperazine derivatives
medicaments containing
Prior art date
Application number
NZ513041A
Other languages
English (en)
Inventor
Daniel Jasserand
Uwe Schon
Holger Sann
Reinhard Bruckner
Christian Eeckhout
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NZ513041A publication Critical patent/NZ513041A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ513041A 2000-07-28 2001-07-18 N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists; their preparation and medicaments containing them NZ513041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10036818A DE10036818A1 (de) 2000-07-28 2000-07-28 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
NZ513041A true NZ513041A (en) 2002-12-20

Family

ID=7650544

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ513041A NZ513041A (en) 2000-07-28 2001-07-18 N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists; their preparation and medicaments containing them

Country Status (27)

Country Link
US (1) US6407106B1 (cg-RX-API-DMAC7.html)
EP (1) EP1176144B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002053577A (cg-RX-API-DMAC7.html)
KR (1) KR100924405B1 (cg-RX-API-DMAC7.html)
CN (1) CN1167698C (cg-RX-API-DMAC7.html)
AR (1) AR028743A1 (cg-RX-API-DMAC7.html)
AT (1) ATE244716T1 (cg-RX-API-DMAC7.html)
AU (1) AU779318B2 (cg-RX-API-DMAC7.html)
BR (1) BR0103048A (cg-RX-API-DMAC7.html)
CA (1) CA2354213C (cg-RX-API-DMAC7.html)
CZ (1) CZ301695B6 (cg-RX-API-DMAC7.html)
DE (2) DE10036818A1 (cg-RX-API-DMAC7.html)
DK (1) DK1176144T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ3119A1 (cg-RX-API-DMAC7.html)
ES (1) ES2201007T3 (cg-RX-API-DMAC7.html)
HU (1) HU226687B1 (cg-RX-API-DMAC7.html)
IL (1) IL144299A (cg-RX-API-DMAC7.html)
IN (1) IN191021B (cg-RX-API-DMAC7.html)
NO (1) NO323233B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ513041A (cg-RX-API-DMAC7.html)
PL (1) PL210436B1 (cg-RX-API-DMAC7.html)
PT (1) PT1176144E (cg-RX-API-DMAC7.html)
RU (1) RU2288918C2 (cg-RX-API-DMAC7.html)
SK (1) SK284802B6 (cg-RX-API-DMAC7.html)
TW (1) TWI304403B (cg-RX-API-DMAC7.html)
UA (1) UA73728C2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200105737B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77515C2 (en) * 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
MXPA04010622A (es) * 2002-04-26 2005-01-25 Lilly Co Eli Derivados de triazol como antagonistas de receptor de taquicinina.
WO2003091227A1 (en) * 2002-04-26 2003-11-06 Eli Lilly And Company Tachykinin receptor antagonists
EP1638944A1 (en) * 2003-06-12 2006-03-29 Eli Lilly And Company Tachykinin receptor antagonists
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same
ATE487704T1 (de) * 2005-07-25 2010-11-15 Hoffmann La Roche Substituierte triazolderivate und ihre verwendung als antagonisten des neurokinin-3-rezeptors
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
CN101641099A (zh) 2007-01-24 2010-02-03 葛兰素集团有限公司 包含3,5-二氨基-6-(2,3-二氯苯基)-1,2,4-三嗪或r(-)-2,4-二氨基-5-(2,3-二氯苯基)-6-氟甲基嘧啶和nk1的药物组合物
US20120258093A1 (en) 2009-08-20 2012-10-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
NO2729147T3 (cg-RX-API-DMAC7.html) 2011-07-04 2018-02-03
US20210015834A1 (en) 2018-02-26 2021-01-21 Ospedale San Raffaele S.R.L. Nk-1 antagonists for use in the treatment of ocular pain
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency
CN115184498B (zh) * 2022-07-15 2023-02-21 山东京卫制药有限公司 N-Boc-哌嗪中有关物质哌嗪的检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883098A (en) 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
IL111730A (en) 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
AU706021B2 (en) * 1995-05-25 1999-06-03 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
GB9513118D0 (en) * 1995-06-28 1995-08-30 Merck Sharp & Dohme Therapeutic agents
CN1209125A (zh) * 1995-12-18 1999-02-24 藤泽药品工业株式会社 作为速激肽拮抗剂的哌嗪类衍生物
KR100458346B1 (ko) * 1996-03-29 2005-06-21 듀파 인터내셔날 리서치 베 파우 피페라진및피페리딘화합물
AUPO735997A0 (en) * 1997-06-17 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
EP0899270B1 (de) * 1997-08-27 2008-05-21 Solvay Pharmaceuticals GmbH Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
DE19824865A1 (de) * 1997-08-27 1999-03-04 Solvay Pharm Gmbh Neue Harnstoffderivate
ES2162731B1 (es) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.

Also Published As

Publication number Publication date
AR028743A1 (es) 2003-05-21
HU0102931D0 (en) 2001-09-28
CZ20011813A3 (cs) 2002-03-13
SK7572001A3 (en) 2002-02-05
UA73728C2 (en) 2005-09-15
DE50100358D1 (de) 2003-08-14
DK1176144T3 (da) 2003-10-27
HU226687B1 (en) 2009-06-29
NO20013709D0 (no) 2001-07-27
BR0103048A (pt) 2002-04-02
KR20020010482A (ko) 2002-02-04
HUP0102931A3 (en) 2003-07-28
ES2201007T3 (es) 2004-03-16
CN1167698C (zh) 2004-09-22
EP1176144A1 (de) 2002-01-30
PL348946A1 (en) 2002-02-11
HUP0102931A2 (hu) 2002-11-28
IL144299A0 (en) 2002-05-23
PL210436B1 (pl) 2012-01-31
CN1335316A (zh) 2002-02-13
CA2354213C (en) 2010-04-27
ATE244716T1 (de) 2003-07-15
CZ301695B6 (cs) 2010-05-26
PT1176144E (pt) 2003-11-28
NO20013709L (no) 2002-01-29
NO323233B1 (no) 2007-02-05
IN191021B (cg-RX-API-DMAC7.html) 2003-09-13
DZ3119A1 (fr) 2004-09-19
US6407106B1 (en) 2002-06-18
HK1042699A1 (en) 2002-08-23
TWI304403B (en) 2008-12-21
IL144299A (en) 2004-08-31
EP1176144B1 (de) 2003-07-09
JP2002053577A (ja) 2002-02-19
AU5767501A (en) 2002-01-31
US20020065276A1 (en) 2002-05-30
DE10036818A1 (de) 2002-02-07
KR100924405B1 (ko) 2009-10-29
RU2288918C2 (ru) 2006-12-10
ZA200105737B (en) 2002-01-22
CA2354213A1 (en) 2002-01-28
AU779318B2 (en) 2005-01-13
SK284802B6 (sk) 2005-11-03

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MY122392A (en) Adamantane derivatives of use of p2x7 receptor antagonists, a process for their preparation, pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions
SE9904505D0 (sv) Novel compounds
ATE316083T1 (de) Adamantanderivate
GB9914486D0 (en) Medicaments
MY141559A (en) Triazole derivatives as tachykinin receptor antagonists
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
SE0200920D0 (sv) Novel compounds
ES2160525A1 (es) Derivados de la 4-aroilpiperidina antagonistas de los receptores ccr-3
NZ513041A (en) N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists; their preparation and medicaments containing them
ES2158813A1 (es) Sales cuaternarias de piperidina antagonistas del receptor ccr-3
ES2159488A1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifugica.
WO2000075107A3 (en) Bradykinin receptor antagonists
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
TNSN03117A1 (en) Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
WO2001010860A3 (en) Quinazolinone and azaquinazolinone derivatives
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
AR022542A1 (es) Derivados de piperidina y piperazina
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
SG146627A1 (en) Imidazole derivatives
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed